Trial in progress: A phase 2, single-arm, open-label study of itacitinib (ITA) for the prevention of chimeric antigen receptor (CAR) T-cell-induced cytokine release syndrome (CRS) Meeting Abstract
| Authors: | Park, J. H.; Frigault, M. J.; Maziarz, R. T.; Nairn, A.; Burke, L.; Tian, C.; Porters, D. L. |
| Abstract Title: | Trial in progress: A phase 2, single-arm, open-label study of itacitinib (ITA) for the prevention of chimeric antigen receptor (CAR) T-cell-induced cytokine release syndrome (CRS) |
| Meeting Title: | Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 26 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2020 Feb 19-23 |
| Meeting Location: | Orlando, FL |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-03-01 |
| Start Page: | S269 |
| Language: | English |
| ACCESSION: | WOS:000516887900404 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2019.12.436 |
| Notes: | Meeting Abstract 405 -- Source: Wos |
